Amendment H-1134 to HF 595
Relating to controlled substances including the manufacture, delivery, or possession of a controlled substance including fentanyl; the manufacture of a controlled substance in the presence of a minor; conspiracy to manufacture for delivery or delivery or intent or conspiracy to deliver a controlled substance to a minor; receipt, provision, and administration of opioid antagonists, including by secondary distributors; providing for immunity; and providing penalties
Failed · March 21, 2023Vote: 35 yeas, 59 nays
Filed March 17, 2023 in the House by
What it changes
- Page 5, after line 4 by inserting: “Sec. ___. Section 124.414, subsection 1, paragraph b, Code 2023, is amended to read as follows: b. “Drug paraphernalia” does not include hypodermic any of the following: (1) Hypodermic needles or syringes if manufactured, delivered, sold, or possessed for a lawful purpose. (2) Equipment, products, or materials used to analyze or test for the presence of fentanyl, a fentanyl analog, or a drug adulterant within a controlled substance.”
- Title page, line 7, after “minor;” by inserting “drug paraphernalia;”
- By renumbering as necessary.